Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 383,928 | 90,326 | 123,794 | 187,675 | 154,901 |
| Marketable Securities | N/A | N/A | N/A | 284,255 | 236,949 |
| Receivables | 331,429 | 269,312 | 248,855 | 234,597 | 204,494 |
| Inventories | 209,873 | 195,019 | 173,303 | 164,318 | 158,034 |
| Other current assets | 137,508 | 124,982 | 108,220 | 101,140 | 91,206 |
| TOTAL | $1,062,738 | $679,639 | $654,172 | $971,985 | $845,584 |
| Non-Current Assets | |||||
| PPE Net | 555,167 | 533,845 | 437,270 | 379,096 | 357,422 |
| Intangibles | 52,543 | 298,192 | 256,314 | 243,719 | 46,155 |
| Other Non-Current Assets | 624,113 | 320,799 | 189,593 | 118,616 | 281,543 |
| TOTAL | $1,231,823 | $1,152,836 | $883,177 | $741,431 | $685,120 |
| Total Assets | $2,294,561 | $1,832,475 | $1,537,349 | $1,713,416 | $1,530,704 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 49,988 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 74,558 | 72,172 | 69,534 | 66,968 | 60,057 |
| Accrued Expenses | 415,648 | 322,938 | 260,683 | 253,418 | 236,131 |
| TOTAL | $582,761 | $725,337 | $770,444 | $1,004,567 | $934,568 |
| Non-Current Liabilities | |||||
| Long Term Debt | 858,492 | 698,910 | 601,348 | 606,075 | 593,110 |
| Deferred Revenues | 42,567 | 41,462 | 41,290 | 29,181 | 27,380 |
| Other Non-Current Liabilities | 162,288 | 148,564 | 84,810 | 95,593 | 38,928 |
| TOTAL | $1,079,005 | $929,313 | $776,138 | $762,691 | $704,349 |
| Total Liabilities | $1,661,766 | $1,654,650 | $1,546,582 | $1,767,258 | $1,638,917 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,426 | 85,330 | 86,007 | 87,123 | 88,005 |
| Common Shares | 10,646 | 10,571 | 10,509 | 10,428 | 10,334 |
| Retained earnings | 2,175,595 | 1,595,648 | 1,167,928 | 803,545 | 540,401 |
| Other shareholders' equity | -48,295 | -40,911 | -36,886 | -29,746 | -37,843 |
| TOTAL | $632,795 | $177,825 | $-9,233 | $-53,842 | $-108,213 |
| Total Liabilities And Equity | $2,294,561 | $1,832,475 | $1,537,349 | $1,713,416 | $1,530,704 |